Assessment of patients with metastatic transitional cell carcinoma of the urinary tract.
暂无分享,去创建一个
K. Steven | H. von der Maase | L. Sengeløv | T. Horn | S. L. Nielsen | C. Kamby | F. Rasmussen | L. Jensen
[1] H. Hansen,et al. The Radner needle a bone-marrow biopsy device. , 2009, Scandinavian journal of haematology.
[2] I. Tannock,et al. Long-term follow-up of a phase III intergroup study of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] S. Fosså,et al. Survival of patients with advanced urothelial cancer treated with cisplatin-based chemotherapy. , 1996, British Journal of Cancer.
[4] L. Sengeløv,et al. Assessment of functional status in patients with invasive carcinoma of the urothelial tract. , 1996, Urologic oncology.
[5] H. Grossman,et al. The relationship of local control to distant metastasis in muscle invasive bladder cancer. , 1995, The Journal of urology.
[6] C. Kamby,et al. 1163 Pattern of metastases in relation to characteristics of primary tumor and treatment in patients (pts) with disseminated urothelial carcinoma (UC) , 1995 .
[7] V. Rangnekar,et al. Identification of bone marrow micrometastases in patients with prostate cancer , 1994, Cancer.
[8] L. Sengeløv,et al. Prognostic factors and significance of chemotherapy in patients with recurrent or metastatic transitional cell cancer of the urinary tract , 1994, Cancer.
[9] R. Edelman,et al. Magnetic resonance imaging (2) , 1993, The New England journal of medicine.
[10] Steinberg Gd,et al. Metastatic bladder cancer. Natural history, clinical course, and consideration for treatment. , 1992 .
[11] Wishnow Ki,et al. Will Rogers and the results of radical cystectomy for invasive bladder cancer. , 1991 .
[12] N. Geller,et al. Prognostic factors for survival of patients with advanced urothelial tumors treated with methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy , 1991, Cancer.
[13] O. S. Nielsen,et al. Bone metastases: pathophysiology and management policy. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] P. R. Timmer,et al. Bladder cancer: pattern of recurrence in 142 patients. , 1985, International journal of radiation oncology, biology, physics.
[15] R. Babaian,et al. Metastases from transitional cell carcinoma of urinary bladder. , 1980, Urology.
[16] W. Shipley,et al. Bladder carcinoma as a systemic disease , 1979, Cancer.
[17] J. Madewell,et al. Metastatic transitional cell carcinoma from the bladder: radiographic manifestions. , 1979, AJR. American journal of roentgenology.
[18] G. Moberger,et al. Classification of bladder tumours based on the cellular pattern. Preliminary report of a clinical-pathological study of 300 cases with a minimum follow-up of eight years. , 1965, Acta chirurgica Scandinavica.
[19] H. von der Maase,et al. Pattern of metastases in relation to characteristics of primary tumor and treatment in patients with disseminated urothelial carcinoma. , 1996, The Journal of urology.
[20] S. Fosså,et al. Clinical significance of routine pre-cystectomy bone scans in patients with muscle-invasive bladder cancer. , 1996, British journal of urology.
[21] R. D. Hunter,et al. WHO Handbook for Reporting Results of Cancer Treatment , 1980 .